Market narrative
Move between stock news, official company releases, crypto, and FX without losing the path back to ticker research.
SOUTH SAN FRANCISCO, Calif., July 31, 2026 (GLOBE NEWSWIRE) -- Vistagen (Nasdaq: VTGN), a late clinical-stage biopharmaceutical company pioneering neuroscience with nose-to-brain neurocircuitry to develop and commercialize a new class of intranasal product candidates called pherines, today announced the appointment of Douglas J.
Press releases
Anchored in the 2026 global campaign's core mission of early detection, equitable access to screening, and compassionate patient support, BioMark advances its multi-marker liquid biopsy to ensure no patient is left behind. Vancouver, British Columbia--(Newsfile Corp. - July 31, 2026) - As the global healthcare community unites on August 1st to observe World Lung Cancer Day, BioMark Diagnostics Inc. (CSE: BUX) (FSE: 20B) (OTCQB: BMKDF) ("BioMark" or the "Company") proudly aligns with leading international healthcare organizations demanding equal access to early detection by developing simple, accessible blood testing that empowers patients and physicians with critical diagnostic insights when it matters most.
ATLANTA--(BUSINESS WIRE)--Cardlytics, Inc. (NASDAQ: CDLX) today announced that on July 29, 2026, the Compensation Committee of Cardlytics' Board of Directors granted an aggregate of 10,320 restricted stock units of Cardlytics to 10 newly hired employees. The restricted stock units were granted as material inducements to employment with Cardlytics in accordance with Nasdaq Listing Rule 5635(c)(4) and were granted under the Cardlytics, Inc. 2022 Inducement Plan (the “2022 Inducement Plan”). For a.
SANTA MARIA, Calif., July 31, 2026 (GLOBE NEWSWIRE) -- AMASS Brands Group (NASDAQ: AMSS) (“AMASS” or “the Company”), a premium, multi-category beverage platform spanning non-alcohol, functional, and alcohol 2.0 products, today announced the expansion of Summer Water Rosé into 37 Costco locations across California, building on the brand's national presence at leading retailers, including Whole Foods, Total Wine, FreshDirect, Foxtrot, H-E-B, Central Market, and more.
New York, New York--(Newsfile Corp. - July 31, 2026) - Kaplan Fox & Kilsheimer LLP announces that a class action lawsuit has been filed against Hub Group, Inc. ("Hub Group" or the "Company") (NASDAQ: HUBG) on behalf of investors that purchased or otherwise acquired Hub Group securities between April 28, 2023 and May 11, 2026 (the "Class Period"). CLICK HERE TO RECEIVE MORE INFORMATION ABOUT THIS INVESTIGATION If you are an investor in Hub Group and have suffered losses, you may CLICK HERE to contact us.
New Nasdaq MVLS delisting rule automatically stayed pending review by the full Commission; Company remains focused on executing its transformation and turnaround plan BOSTON, MA, July 31, 2026 (GLOBE NEWSWIRE) -- Netcapital Inc. (Nasdaq: NCPL) (the “Company”) today provided an update to shareholders regarding a significant regulatory development affecting Nasdaq-listed companies, including the Company: the stay of a recently approved Nasdaq continued listing rule that would have subjected companies with a market value of listed securities (“MVLS”) below $5 million to immediate suspension and delisting. Background on New MVLS Rule On July 22, 2026, the staff of the Securities and Exchange Commission's Division of Trading and Markets, acting pursuant to delegated authority, approved a Nasdaq rule change (File No.
BISMARCK, N.D.--(BUSINESS WIRE)--Everus Construction Group (NYSE: ECG) announced today that it has entered into a definitive agreement to acquire Epsilon Industries, a premier designer and manufacturer of complex, modular mechanical and electrical building infrastructure systems, for $295 million in cash, subject to customary adjustments. With more than 25 years of experience providing off-site construction solutions across North America, Epsilon is recognized in the industry for its innovation.
JERSEY CITY, N.J.--(BUSINESS WIRE)--Organon (NYSE: OGN), a global healthcare company with a mission to deliver impactful medicines and solutions for a healthier every day, announced today that the company's Board of Directors declared a quarterly dividend of $0.02 for each issued and outstanding share of the company's common stock. The dividend is payable on September 10, 2026, to stockholders of record at the close of business on August 14, 2026. About Organon Organon (NYSE: OGN) is a global h.
Vancouver, British Columbia--(Newsfile Corp. - July 31, 2026) - Red Lake Gold Inc. (CSE: RGLD) ("Red Lake Gold" or the
Vancouver, British Columbia--(Newsfile Corp. - July 31, 2026) - Visionary Metals Corp. (TSXV: VIZ) ("Visionary" or the "Company") is pleased
Boston, Massachusetts, July 31, 2026 (GLOBE NEWSWIRE) -- HYCU, Inc. , the #1 AI Resilience company, proudly announced today that CRN UK, a brand of The Channel Company, has recognised Wendy Inwood, Senior Manager, EMEA Channel at HYCU on the prestigious Women of the Channel EMEA list for 2026.
SAN MATEO, Calif.--(BUSINESS WIRE)--Franklin Resources, Inc. (the “Company”) [NYSE: BEN] today announced net income1 of $171.5 million or $0.31 per diluted share for the quarter ended June 30, 2026, as compared to $268.2 million or $0.49 per diluted share for the previous quarter, and $92.3 million or $0.15 per diluted share for the quarter ended June 30, 2025. Operating income was $215.8 million for the quarter ended June 30, 2026, as compared to $323.3 million for the previous quarter and $15.
Did you buy WIX securities between February 19, 2025 and May 12, 2026? Did you buy WIX securities between February 19, 2025 and May 12, 2026?
TEL AVIV, Israel, July 31, 2026 (GLOBE NEWSWIRE) -- SciSparc Ltd. (Nasdaq: SPRC) (“Company” or “SciSparc”), today announced that NeuroThera Labs Inc. (TSXV: NTLX) ("NeuroThera"), a clinical-stage pharmaceutical company focused on developing novel treatments for central nervous system disorders, announced another technological milestone achieved by NeuroThera's quantum sampling workflow platform for clinical trials data analytics (the “Platform”).
Vancouver, British Columbia--(Newsfile Corp. - July 31, 2026) - WELL Health Technologies Corp. (TSX: WELL) (OTCQX: WHTCF) ("WELL"), a digital health company focused on positively impacting health outcomes by leveraging technology to empower healthcare practitioners and their patients globally, is pleased to announce that its subsidiary, WELLSTAR Technologies Corp. ("WELLSTAR"), has closed a financing transaction for aggregate gross proceeds of C$50 million (the "Financing"), consisting of C$36.2 million of gross proceeds for WELLSTAR pursuant to a treasury offering of subscription receipts (the "Treasury Offering") and C$13.8 million of gross proceeds for an existing shareholder through a secondary offering (the "Secondary Offering"). The Financing was anchored by a large Canadian bank-owned asset manager and included new institutional investors, alongside continued support from existing shareholders, including WELL and certain members of WELL and WELLSTAR management, board of directors, and employees.
New York, New York--(Newsfile Corp. - July 31, 2026) - Kaplan Fox & Kilsheimer LLP announces that a class action lawsuit has been filed against Badger Meter, Inc. ("Badger Meter" or the "Company") (NYSE: BMI) on behalf of investors that purchased or otherwise acquired Badger Meter securities between April 18, 2024 and April 16, 2026 (the "Class Period"). CLICK HERE TO JOIN THE CASE If you are an investor in Badger Meter and have suffered losses, you may CLICK HERE to contact us.
New York, New York--(Newsfile Corp. - July 31, 2026) - Kaplan Fox & Kilsheimer LLP announces that a class action lawsuit has been filed against PicS N.V. ("PicS" or the "Company") (NASDAQ: PICS) on behalf of all persons or entities who purchased PicS Class A common stock in and/or traceable to PicS' initial public offering ("IPO") on or around January 30, 2026.
Announces Regular Quarterly Cash Dividend of $0.20 Per Share Reaffirms Full-Year 2026 Revenue and Earnings Guidance Reports revenue of $20.5 million for the second quarter of 2026, which increased by $0.1 million, or 0.5% compared to the same period in 2025. Reports GAAP diluted EPS of $0.41 and non-GAAP diluted EPS of $0.46 for the second quarter of 2026.
RADNOR, Pa.--(BUSINESS WIRE)--Lincoln Financial (NYSE: LNC) announced today that the board of directors of Lincoln National Corporation has declared the following preferred stock dividends: Semi-annual dividend of $1,156.25 per share on the corporation's 9.250% Fixed Rate Reset Non-Cumulative Preferred Stock, Series C, $25,000 liquidation preference per share, represented by depositary shares each representing a 1/25th interest in a share of the preferred stock, holders of which will receive $4.
Prior venetoclax failure — a setting in which published salvage remission rates are approximately 13% and median survival approximately 2.4 months — shows no adverse impact on blinded composite remission rates as MIRACLE approaches the end of Part A
